Funds and ETFs Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Pharmaceuticals

Delayed BME 11:35:10 2024-04-30 am EDT 5-day change 1st Jan Change
84.3 EUR +1.93% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. +6.10% +40.03%

ETFs positioned on Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. Net sales break down by family of products as follows: - pharmaceutical products manufactured under contract (49%); - prescription pharmaceuticals (45%): intended for preventing and treating venous thrombo-embolic disease, post-menopausal osteoporosis, muscle pain, tooth and mouth infections, angina, osteoarthritis, etc.; - diagnostic products (6%): contrast products used in medical imaging with magnetic resonance, ultrasound, or X-rays. The group also offers hospital products and non-prescription pharmaceuticals. Net sales break down by source of revenue between sales of products (50.6%), sales of services (49.3%) and sales of licenses (0.1%). Net sales are distributed geographically as follows: Spain (33%), European Union (17.3%), OECD countries (45.9%) and other (3.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
84.3 EUR
Average target price
85.12 EUR
Spread / Average Target
+0.98%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Funds and ETFs Laboratorios Farmaceuticos Rovi, S.A.